查詢結果分析
相關文獻
- A Dose-Dependent Pharmacokinetic Study of Levodopa by Intramuscular Administration in Rabbits
- Absorption and Disposition Kinetics of Trimethoprim Following Intramuscular Injection in Rabbits
- 抗菌劑在養殖魚類的藥物動力學研究(1)--在不同給藥方式下點帶石斑Epinephelus coioides對Flumequine之吸收、分布與排除
- The Role of CD 夰狇Cells and CD11a in the Rejection-Reaction of the Allogeneic Microskin Grafting
- 選擇性血清素再吸收抑制劑
- Fluvoxamine對Clozapine藥物動力學之影響
- 藥物動力學在臨床上之應用:藥物動力學服務
- 碳酸酐酶抑制劑6-Hydroxyethoxy-2-benzothiazole Sulfonamide靜脈注射後之兔眼藥物動力學
- 碳酸酐酶抑制劑6-Hydroxyethoxyzolamide局部點眼後之兔眼藥物動力學
- 新抗癲癇藥
頁籤選單縮合
題 名 | A Dose-Dependent Pharmacokinetic Study of Levodopa by Intramuscular Administration in Rabbits=在兔子肌肉注射模式中Levodopa劑量依存性(Does-dependence)之藥物動力學研究 |
---|---|
作 者 | 王莉萱; 許光陽; 徐鳳麟; 林淑娟; | 書刊名 | 藥物食品分析 |
卷 期 | 16:5 2008.10[民97.10] |
頁 次 | 頁21-27+103 |
分類號 | 418.1 |
關鍵詞 | 藥物動力學; 肌肉注射; 生物可用率; 左多巴; 兔子; Pharmacokinetics; Intramuscular; Bioavailability; L-dopa; Rabbit; |
語 文 | 英文(English) |
英文摘要 | The dose-dependent pharmacokinetics of levodopa (L-dopa) was studied in rabbits by intramuscular administration. Three different doses of L-dopa/carbidopa (2/0.5, 5/1.25, and 10/2.5 mg/kg) were administered to six male rabbits via an intramuscular (IM) route, and one dose of L-dopa/carbidopa (2/0.5 mg/kg) was administered via an intravenous (IV) route with a washout period of 1-week between different doses. Plasma samples were collected after each treatment and the concentrations of L-dopa and 3-O-methyldopa (an L-dopa metabolite, 3-OMD) were measured by a sensitive high-performance liquid chromatographic (HPLC) method. Subsequently, these measurements were used to determine the pharmacokinetic behavior of L-dopa and 3-OMD. The results indicated that the absorption of L-dopa was fast with the time to the peak within 30 min, but the formation of 3-OMD was slow with the time to the peak of 120-180 min after IM administration. The IM bioavailability of L-dopa was in the range of 0.70-1.21, and the relative ratios of the formation of 3-OMD at different doses of L-dopa were in the range of 0.79-1.24. No statistically significant difference could be observed for IM bioavailability of L-dopa or for the relative ratios of the formation of 3-OMD in this dose range. The elimination half-lives of L-dopa and 3-OMD also exhibited no significant differences for each dose after IM administration. In addition, both the area under the curve (AUC) and maximum plasma concentration (Cmax) values of L-dopa and 3-OMD increased proportionally over the dose range of 2/0.5-10/2.5 mg/kg for L-dopa/carbidopa, suggesting that L-dopa and 3-OMD obeyed dose-independent pharmacokinetics. |
本系統中英文摘要資訊取自各篇刊載內容。